-
Study aim
-
The main objectives:
Evaluation of the effectiveness of TAME treatment in the patients with severe osteoarthritis of the knee
Sub-objectives:
determination of mean age, gender and BMI distribution, duration of pain, Kellgren and Lawrence classification (KL), pain intensity (before, one, three and 6 months after treatment) in patients with sever knee osteoarthritis referred for TAME treatment
-
Design
-
single-blinded before-after clinical trial on 30 patients
-
Settings and conduct
-
After local anesthesia and injection of 2000 units of heparin, angiography will be performed in the genicular, patellar and tibial arteries. The patient will be asked about the location of the pain, and if the site of pain matches a site with abnormal staining, embolization will be done using 2 units of polyvinyl alcohol 355/500,following pain severity will be measured based on VAS from 1-10. The data analyzer is blind to clinical outcome.
-
Participants/Inclusion and exclusion criteria
-
inclusion:severe osteoarthritis (KL grade 4) without age and sex limitation . Receive at least 3 months of outpatient treatments including NSAIDs, opioids and intra-articular hyaluronic acid injection and physiotherapy (muscle strengthening) without improvement. surgery contraindication due to medical conditions (i.e cardiovascular disease).
exclusion: malignancy, local infection, rheumatoid arthritis, history of knee surgery, advanced atherosclerosis.
-
Intervention groups
-
before-after clinical trial on the effect of TAME on patients with severe knee joint osteoarthritis
-
Main outcome variables
-
Studies have not shown major complications such as osteonecrosis, septic arthritis, or cases lead to hospitalization. Minor complications: Erythema at the site of embolization (most common 11%), hematoma at the puncture site (10%), paresthesia (1%) and fever (about 0.5%)